4th Circ. Revives Purdue Pharma OxyContin FCA Row

Law360, New York (December 12, 2013, 3:04 PM EST) -- The Fourth Circuit on Thursday revived a qui tam lawsuit accusing Purdue Pharma LP of violating the False Claims Act by falsely marketing painkiller OxyContin, vacating a lower court’s ruling that had tossed the case for being virtually identical to a previous one that was dismissed after being brought by the relator’s husband.

A three-judge panel found that the res judicata doctrine — which bars the filing of new cases that are nearly identical to cases that have already been litigated to conclusion — does not...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

US ex rel. Steven May v. Purdue Pharma L.P.


Case Number

12-2287

Court

Appellate - 4th Circuit

Nature of Suit

2890 Other Statutory Actions

Date Filed

October 18, 2012

Law Firms

Companies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.